LUIS
BRIEVA RUIZ
CON
![Foto de LUIS](/img/nophoto.png)
![Foto de Hospital Universitari de Girona Dr. Josep Trueta](/img/noimage_org.png)
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublications in collaboration with researchers from Hospital Universitari de Girona Dr. Josep Trueta (26)
2024
-
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
Neurologia, Vol. 39, Núm. 2, pp. 196-208
2023
-
Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs
JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403
-
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Gadolinium-enhanced brain lesions in multiple sclerosis relapse
Neurologia, Vol. 37, Núm. 7, pp. 557-563
-
Recommendations for the diagnosis and treatment of multiple sclerosis relapses
Journal of Personalized Medicine, Vol. 12, Núm. 1
2021
-
Direct costs of relapses in patients with relapsing-remitting multiple sclerosis
Neurology Perspectives, Vol. 1, Núm. 3, pp. 160-169
2019
-
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
European Journal of Neurology, Vol. 26, Núm. 3, pp. 525-532
-
Review of the novelties presented at the 2018 ECTRIMS congress: 11th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 68, Núm. 11, pp. 468-479
-
Review of the novelties presented at the 2018 ectrims congress: 11th post-ectrims meeting (I)
Revista de Neurologia, Vol. 68, Núm. 10, pp. 431-441
2018
-
Review of the novelties from the 2017 ECTRIMS congress, presented at the 10th post-ectrims meeting (I)
Revista de Neurologia, Vol. 67, Núm. 1, pp. 15-27
-
Review of the novelties from the 2017 ectrims congress, presented at the 10th post-ectrims meeting (II)
Revista de Neurologia, Vol. 67, Núm. 2, pp. 50-62
2016
-
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses
Multiple Sclerosis, Vol. 22, Núm. 1, pp. 117-121
-
Long-term adherence to IFN beta-1a treatment when using rebismart1device in patients with relapsing-remitting multiple sclerosis
PLoS ONE, Vol. 11, Núm. 8
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
Review of the novelties from the 2014 ECTRIMS-ACTRIMS joint congress, presented at the 7th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 61, Núm. 6, pp. 271-283
-
Review of the novelties from the 2014 ectrims-actrims joint congress, presented at the 7th post-ectrims meeting (i)
Revista de Neurologia, Vol. 61, Núm. 5, pp. 215-224
2014
-
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)
Revista de Neurologia, Vol. 59, Núm. 7, pp. 307-316